vs
Side-by-side financial comparison of Navitas Semiconductor Corp (NVTS) and Relay Therapeutics, Inc. (RLAY). Click either name above to swap in a different company.
Navitas Semiconductor Corp is the larger business by last-quarter revenue ($7.3M vs $7.0M, roughly 1.0× Relay Therapeutics, Inc.). Navitas Semiconductor Corp produced more free cash flow last quarter ($-8.2M vs $-235.9M).
Navitas Semiconductor Corp is a leading global semiconductor firm specializing in gallium nitride (GaN) power integrated circuits. Its high-efficiency, compact power solutions serve consumer electronics, electric vehicles, renewable energy, and industrial sectors, with clients spanning North America, Asia, and Europe.
Relay Therapeutics is a clinical-stage biotechnology company focused on developing precision oncology therapies. It leverages advanced computational modeling of protein dynamics, paired with cutting-edge experimental biology, to design targeted medicines for previously intractable cancer types, serving global oncology care markets and patient populations.
NVTS vs RLAY — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $7.3M | $7.0M |
| Net Profit | $-31.8M | — |
| Gross Margin | 38.1% | — |
| Operating Margin | -567.3% | — |
| Net Margin | -436.1% | — |
| Revenue YoY | -59.4% | — |
| Net Profit YoY | 20.2% | — |
| EPS (diluted) | $-0.14 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $7.3M | $7.0M | ||
| Q3 25 | $10.1M | $0 | ||
| Q2 25 | $14.5M | — | ||
| Q1 25 | $14.0M | $7.7M | ||
| Q4 24 | $18.0M | $0 | ||
| Q3 24 | $21.7M | $0 | ||
| Q2 24 | $20.5M | $0 | ||
| Q1 24 | $23.2M | $10.0M |
| Q4 25 | $-31.8M | — | ||
| Q3 25 | $-19.2M | $-74.1M | ||
| Q2 25 | $-49.1M | — | ||
| Q1 25 | $-16.8M | $-77.1M | ||
| Q4 24 | $-39.9M | — | ||
| Q3 24 | $-18.7M | $-88.1M | ||
| Q2 24 | $-22.3M | $-92.2M | ||
| Q1 24 | $-3.7M | $-81.4M |
| Q4 25 | 38.1% | — | ||
| Q3 25 | 37.9% | — | ||
| Q2 25 | 16.1% | — | ||
| Q1 25 | 37.9% | — | ||
| Q4 24 | 12.4% | — | ||
| Q3 24 | 39.7% | — | ||
| Q2 24 | 39.0% | — | ||
| Q1 24 | 41.1% | — |
| Q4 25 | -567.3% | — | ||
| Q3 25 | -192.0% | — | ||
| Q2 25 | -149.4% | — | ||
| Q1 25 | -180.5% | -1105.2% | ||
| Q4 24 | -216.9% | — | ||
| Q3 24 | -133.6% | — | ||
| Q2 24 | -152.1% | — | ||
| Q1 24 | -136.2% | -903.0% |
| Q4 25 | -436.1% | — | ||
| Q3 25 | -190.2% | — | ||
| Q2 25 | -338.7% | — | ||
| Q1 25 | -120.1% | -1003.6% | ||
| Q4 24 | -221.7% | — | ||
| Q3 24 | -86.4% | — | ||
| Q2 24 | -109.1% | — | ||
| Q1 24 | -15.9% | -813.3% |
| Q4 25 | $-0.14 | — | ||
| Q3 25 | $-0.09 | $-0.43 | ||
| Q2 25 | $-0.25 | — | ||
| Q1 25 | $-0.09 | $-0.46 | ||
| Q4 24 | $-0.22 | — | ||
| Q3 24 | $-0.10 | $-0.63 | ||
| Q2 24 | $-0.12 | $-0.69 | ||
| Q1 24 | $-0.02 | $-0.62 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $236.9M | $84.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $443.7M | $567.1M |
| Total Assets | $500.5M | $621.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $236.9M | $84.0M | ||
| Q3 25 | $150.6M | $91.6M | ||
| Q2 25 | $161.2M | — | ||
| Q1 25 | $75.1M | $93.5M | ||
| Q4 24 | $86.7M | $124.3M | ||
| Q3 24 | $98.3M | $152.4M | ||
| Q2 24 | $111.7M | $134.1M | ||
| Q1 24 | $128.9M | $152.9M |
| Q4 25 | $443.7M | $567.1M | ||
| Q3 25 | $371.0M | $607.7M | ||
| Q2 25 | $388.9M | — | ||
| Q1 25 | $341.8M | $721.1M | ||
| Q4 24 | $348.0M | $777.8M | ||
| Q3 24 | $380.8M | $838.9M | ||
| Q2 24 | $388.1M | $681.7M | ||
| Q1 24 | $397.9M | $745.8M |
| Q4 25 | $500.5M | $621.3M | ||
| Q3 25 | $430.2M | $670.0M | ||
| Q2 25 | $449.4M | — | ||
| Q1 25 | $370.8M | $799.4M | ||
| Q4 24 | $390.0M | $871.3M | ||
| Q3 24 | $419.4M | $930.1M | ||
| Q2 24 | $439.1M | $772.5M | ||
| Q1 24 | $467.9M | $841.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.1M | $-235.5M |
| Free Cash FlowOCF − Capex | $-8.2M | $-235.9M |
| FCF MarginFCF / Revenue | -111.8% | -3370.0% |
| Capex IntensityCapex / Revenue | 0.7% | 5.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-44.4M | $-622.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-8.1M | $-235.5M | ||
| Q3 25 | $-10.0M | $-62.1M | ||
| Q2 25 | $-11.2M | — | ||
| Q1 25 | $-13.5M | $-73.2M | ||
| Q4 24 | $-10.2M | $-249.1M | ||
| Q3 24 | $-13.7M | $-75.1M | ||
| Q2 24 | $-15.1M | $-65.8M | ||
| Q1 24 | $-19.8M | $-50.3M |
| Q4 25 | $-8.2M | $-235.9M | ||
| Q3 25 | $-10.7M | $-62.1M | ||
| Q2 25 | $-11.9M | — | ||
| Q1 25 | $-13.6M | $-73.6M | ||
| Q4 24 | $-10.8M | $-251.1M | ||
| Q3 24 | $-14.3M | $-75.3M | ||
| Q2 24 | $-17.9M | $-65.8M | ||
| Q1 24 | $-22.7M | $-52.1M |
| Q4 25 | -111.8% | -3370.0% | ||
| Q3 25 | -106.1% | — | ||
| Q2 25 | -82.2% | — | ||
| Q1 25 | -96.8% | -958.4% | ||
| Q4 24 | -59.8% | — | ||
| Q3 24 | -65.9% | — | ||
| Q2 24 | -87.3% | — | ||
| Q1 24 | -97.9% | -520.7% |
| Q4 25 | 0.7% | 5.9% | ||
| Q3 25 | 7.0% | — | ||
| Q2 25 | 4.7% | — | ||
| Q1 25 | 0.3% | 5.0% | ||
| Q4 24 | 3.1% | — | ||
| Q3 24 | 2.6% | — | ||
| Q2 24 | 13.4% | — | ||
| Q1 24 | 12.5% | 17.8% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
